⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ORKA News
Oruka Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
ORKA
Form 8-K
sec.gov
ORKA
Phase 2 Data could Transform these Biotechs from Clinical Promise to Market Validation
globenewswire.com
NTHI
ORKA
ABVX
SYRE
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
globenewswire.com
ORKA
Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ORKA
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
globenewswire.com
ACHV
ORKA
EWTX
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology
prnewswire.com
ORKA
HALO
Form 8-K
sec.gov
ORKA
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
globenewswire.com
ORKA
Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering
globenewswire.com
ORKA